Guidelines for Stability Testing of Orphan Drugs as per US FDA Guidelines
1) Purpose
The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing of orphan drugs in compliance with US FDA requirements. This SOP ensures that stability data for orphan drugs supports their quality, safety, and efficacy throughout the intended shelf life.
2) Scope
This SOP applies to all personnel involved in the design, execution, and documentation of stability studies for orphan drugs intended for the US market.
3) Responsibilities
Stability Testing Team: Responsible for conducting stability studies and documenting results for orphan drugs as per US FDA guidelines.
Quality Assurance (QA) Team: Responsible for reviewing and approving stability study protocols and reports.
Regulatory Affairs Team: Responsible for ensuring that stability studies comply with FDA regulations specific to orphan drugs.
4) Procedure
4.1 Preparation for Stability Testing
4.1.1 Obtain and review
4.1.2 Develop a stability protocol specific to orphan drugs, including study design, testing schedule, storage conditions, and testing parameters as per FDA guidelines.
4.2 Selection of Batches and Samples
4.2.1 Select representative batches of the orphan drug, typically three primary batches manufactured using the proposed
4.2.2 Prepare sufficient samples to cover the entire study duration, considering the number of time points and tests to be conducted.
4.3 Defining Storage Conditions and Time Points
4.3.1 Define the storage conditions according to FDA guidelines, considering any specific requirements for orphan drugs, such as low volume production.
4.3.2 Establish the time points for sampling, such as 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and additional time points for accelerated studies.
4.4 Conducting Stability Tests
4.4.1 Store samples under the defined conditions, monitoring temperature and humidity to ensure compliance with the set parameters.
4.4.2 At each specified time point, remove samples and conduct stability-indicating tests, including physical, chemical, and microbiological tests, as applicable.
4.4.3 Record all results meticulously in stability data sheets, ensuring accuracy and traceability of data.
5) Abbreviations, if any
FDA: United States Food and Drug Administration
QA: Quality Assurance
6) Documents, if any
Stability protocol, stability data sheets, stability testing records, stability report, submission package to FDA.
7) Reference, if any
FDA Guidance for Industry: Stability Testing of Drug Products for Orphan Drugs.
8) SOP Version
Version 1.0